Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dutch STRIDER Trial
NL-OMON47435Phase 3Recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in intrauterine growth restriction (IUGR) comparing Sildenafil with Placebo (2 arms). Primary endpoint: Perinatal healthy survival. Started Jan 2015; status: recruiting.
02
Drugs
sildenafil
03
Conditions
intrauterine growth restriction (IUGR)
Beyond the preview
Go deeper on NL-OMON47435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON47435.